A. Feliciano v. PA DOC

CourtCommonwealth Court of Pennsylvania
DecidedApril 13, 2021
Docket588 M.D. 2019
StatusPublished

This text of A. Feliciano v. PA DOC (A. Feliciano v. PA DOC) is published on Counsel Stack Legal Research, covering Commonwealth Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
A. Feliciano v. PA DOC, (Pa. Ct. App. 2021).

Opinion

IN THE COMMONWEALTH COURT OF PENNSYLVANIA

Anthony Feliciano, : Petitioner : v. : No. 588 M.D. 2019 : SUBMITTED: March 17, 2021 Pennsylvania Department : of Corrections, : Respondent :

BEFORE: HONORABLE P. KEVIN BROBSON, President Judge HONORABLE RENÉE COHN JUBELIRER, Judge HONORABLE ANNE E. COVEY, Judge HONORABLE MICHAEL H. WOJCIK, Judge HONORABLE CHRISTINE FIZZANO CANNON, Judge HONORABLE ELLEN CEISLER, Judge HONORABLE J. ANDREW CROMPTON, Judge

OPINION BY JUDGE CEISLER FILED: April 13, 2021

Petitioner Anthony Feliciano (Feliciano), an inmate currently incarcerated within the Commonwealth’s state prison system at the State Correctional Institution at Mahanoy (SCI-Mahanoy), has filed a Petition for Review in this Court’s original jurisdiction. He seeks a declaratory judgment establishing that Respondent, Pennsylvania Department of Corrections (Department), violated his procedural due process rights during the course of punishing him for a positive drug test. In response, the Department has filed preliminary objections, demurring to the Petition for Review and challenging our jurisdiction to consider this matter. For the reasons explained infra, we sustain the Department’s preliminary objection to our jurisdiction and dismiss the Petition for Review without prejudice. I. Facts and Procedural History In May 2019, Feliciano’s urine was collected so that it could be tested for the presence of illicit substances. Pet. for Review, ¶5, Ex. A.1 In August 2019, Phamatech Laboratories, located in San Diego, California, issued a report indicating that Feliciano’s sample had tested positive for Buprenorphine2 in the amount of 11 nanograms per milliliter. Id., ¶6, Ex. A. As a consequence, Feliciano was placed in the Restricted Housing Unit (RHU) at SCI-Mahanoy on August 6, 2019. Id., ¶7. Contemporaneously, the Department issued Misconduct Report D 198445 (first misconduct report) and allegedly served it on Feliciano. Id., Ex. B. In response, Feliciano filed an Official Inmate Grievance, numbered 817513 (first grievance), with the Department. Id., Ex. C. Hearing Examiner F. Nunez dismissed the first misconduct report without prejudice on August 9, 2019. Id., ¶10, Ex. D.3 Despite Examiner Nunez’s decision, the Department still rejected Feliciano’s first grievance on August 12, 2019. Id., Ex. C. Facility Grievance Coordinator Jane Hinman formally notified Feliciano that she had rejected the first

1 Exhibit A, which is a printout of Feliciano’s drug test results, indicates that urine was collected from Feliciano on July 29, 2019, not May 29, 2019. This discrepancy, however, has no bearing on our analysis in this matter. 2 Buprenorphine is a medication approved by the Food and Drug Administration for treatment of opioid addiction and is intended for use in combination with counseling and behavioral therapy. Buprenorphine, U.S. DEP’T OF HEALTH & HUMAN SERVS., SUBSTANCE ABUSE AND MENTAL HEALTH SERVS. ADMIN., https://www.samhsa.gov/medication-assisted-treatment/ medications-counseling-related-conditions/buprenorphine (last visited April 12, 2021). “[Buprenorphine] produces effects such as euphoria or respiratory depression at low to moderate doses . . . . Because of [B]uprenorphine’s opioid effects, it can be misused, particularly by people who do not have an opioid dependency.” Id. Buprenorphine is a Schedule III controlled substance under Pennsylvania law. See 28 Pa. Code § 25.72(d)(10). 3 This Disciplinary Hearing Report lists the hearing date as being September 9, 2019. Pet. for Review, Ex. D. We believe this date to be a typographical error, in light of the sequence of events in this matter and Feliciano’s statements in his Petition for Review, and that the actual date of this hearing was August 9, 2019.

2 grievance due to its nonconformance with the Department’s administrative policies pertaining to “Inmate Discipline/Misconduct Procedures” and “Administrative Custody Procedures[.]” Id., Ex. E. Coordinator Hinman directed Feliciano to discuss the grieved matter with SCI-Mahanoy’s Program Review Committee (PRC). Id.4 Shortly thereafter, Feliciano filed a second Official Inmate Grievance on August 15, 2019, numbered 819156 (second grievance), which Coordinator Hinman appears to have rejected the following day. Id., Ex. F.5 Feliciano promptly filed a third Official Inmate Grievance on August 20, 2019, numbered 820178 (third grievance). Id., Ex. G. In his third grievance, Feliciano stated that he had not been given “any type of paperwork, misconduct, etc.” regarding the disciplinary charges that had resulted in his placement in the RHU. Id. Feliciano claimed that the Department had consequently violated his due

4 The Department has described the PRC as: [a] committee consisting of three (3) staff members that conducts Administrative Custody Hearings, periodic reviews, makes decisions regarding continued confinement in the [RHU] and/or Special Management Unit (SMU), and hears all first level appeals of misconducts. The committee shall consist of one staff member from each of the following classifications: Deputy Superintendent, who shall serve as the chairperson, Inmate Program Manager, Unit Manager, School Principal, Drug and Alcohol Treatment Specialist Supervisor, or Inmate Records Officer Supervisor and a Commissioned Officer. The Superintendent may designate other staff as committee members[;] however, if such designations are made, they must be in writing and the Superintendent must maintain a list of all designees. Whenever a [PRC] is convened, at least one (1) member of the committee must be a staff member who is not directly involved in the administration of the RHU/SMU in which the inmate is currently housed. DEP’T OF CORR., DC ADM 004 (1999), https://www.cor.pa.gov/About%20Us/Documents/ DOC%20Policies/004%20Criminal%20Violations.pdf (last visited April 12, 2021). 5 On the second grievance, the blank for the facility grievance coordinator’s signature contains only the handwritten word “[r]eject.” Pet. for Review, Ex. F.

3 process rights pursuant to the United States Constitution’s Fifth, Eighth, and Fourteenth Amendments6 and demanded “$30,000 for violated rights and pain and suffering.” Id. Five days later, Coordinator Hinman formally notified Feliciano that she had rejected his second grievance because it did not conform to the Department’s administrative policies pertaining to “Inmate Discipline/Misconduct Procedures.” Id., Ex. H. That same day, the Department issued Misconduct Report D 169129 (second misconduct report) and allegedly served it upon Feliciano. Id., Ex. I. The second misconduct report stated, in relevant part: MISCONDUCT CHARGE OR OTHER ACTION[:] A. Class I. Charge #22[:] Possession or use of a dangerous or controlled substance. STAFF MEMBER’S VERSION[:] On July 29, 2019[,] . . . Feliciano . . . submitted a urine test to detect the presence of drugs in his system. The test sample was sent to [Phamatech] Laboratories . . . for analysis. On August 2, 2019[,] [Phamatech] Laboratories informed the institution that Feliciano’s urine test was positive for the presence of Buprenorphine (11ng/mL). A [gas chromatography–mass spectrometry] retest of the sample indicated a positive result for Buprenorphine. Note: Date of report and date of incident differ due to original misconduct being dismissed without prejudice. IMMEDIATE ACTION TAKEN[:] Misconduct warranted. Not considered for informal resolution due to seriousness of charge. Refer to Hearing Examiner for further review. PREHEARING CONFINEMENT[:] “No.”[7]

6 U.S. CONST. amends. V, VIII, and XIV. 7 It is not clear why this report states that Feliciano was not held in pre-hearing confinement, given that Feliciano was detained in restricted housing between August 6, 2019, the

4 Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wolff v. McDonnell
418 U.S. 539 (Supreme Court, 1974)
Meachum v. Fano
427 U.S. 215 (Supreme Court, 1976)
Sandin v. Conner
515 U.S. 472 (Supreme Court, 1995)
Griffin v. Vaughn
112 F.3d 703 (Third Circuit, 1997)
Wilkinson v. Austin
545 U.S. 209 (Supreme Court, 2005)
Brown v. Blaine
833 A.2d 1166 (Commonwealth Court of Pennsylvania, 2003)
Chem v. Horn
725 A.2d 226 (Commonwealth Court of Pennsylvania, 1999)
Bronson v. Central Office Review Committee
721 A.2d 357 (Supreme Court of Pennsylvania, 1998)
Clark v. Beard
918 A.2d 155 (Commonwealth Court of Pennsylvania, 2007)
Stone Crushed Partnership v. Kassab Archbold Jackson & O'Brien
908 A.2d 875 (Supreme Court of Pennsylvania, 2006)
Robson v. BIESTER
420 A.2d 9 (Commonwealth Court of Pennsylvania, 1980)
Weaver v. Pennsylvania Department of Corrections
829 A.2d 750 (Commonwealth Court of Pennsylvania, 2003)
Luckett v. Blaine
850 A.2d 811 (Commonwealth Court of Pennsylvania, 2004)
Lawson v. PA. DEPT. OF CORR.
539 A.2d 69 (Commonwealth Court of Pennsylvania, 1988)
Yassin Aref v. Loretta Lynch
833 F.3d 242 (D.C. Circuit, 2016)
Key v. Pa. Dep't of Corr.
185 A.3d 421 (Commonwealth Court of Pennsylvania, 2018)
Commonwealth v. Hicks, M., Aplt.
208 A.3d 916 (Supreme Court of Pennsylvania, 2019)
Hill v. Department of Corrections
64 A.3d 1159 (Commonwealth Court of Pennsylvania, 2013)
Lopez v. Pa. Department of Corrections
119 A.3d 1081 (Commonwealth Court of Pennsylvania, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
A. Feliciano v. PA DOC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/a-feliciano-v-pa-doc-pacommwct-2021.